Timing is everything: study tests new order for lung cancer drugs
NCT ID NCT04163432
Summary
This study is testing if changing the order of two standard treatments—chemotherapy and immunotherapy—can improve results for people with advanced non-small cell lung cancer that has spread. It will compare two schedules: one where chemo is given a week before the immunotherapy, and another where the order is reversed. The goal is to see if this staggered timing helps control the cancer better and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.